NADPH Selective Depletion Nanomedicine‐Mediated Radio‐Immunometabolism Regulation for Strengthening Anti‐PDL1 Therapy against TNBC

Anti‐PD(L)1 immunotherapy recently arises as an effective treatment against triple‐negative breast cancer (TNBC) but is only applicable to a small portion of TNBC patients due to the low PD‐L1 expression and the immunosuppressive tumor microenvironment (TME). To address these challenges, a multifunc...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Ying, Gao, Di, Jin, Lin, Ren, Xuechun, Ouyang, Yanan, Zhou, Ying, He, Xinyu, Jia, Liangliang, Tian, Zhongmin, Wu, Dingcai, Yang, Zhe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9875612/
https://www.ncbi.nlm.nih.gov/pubmed/36403210
http://dx.doi.org/10.1002/advs.202203788

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9875612/
https://www.ncbi.nlm.nih.gov/pubmed/36403210
http://dx.doi.org/10.1002/advs.202203788

Ejemplares similares